In breast cancer, depletion of BCL9L by knockdown experiments inhibits the cell proliferation of MCF7 cells, while overexpression of BCL9L promotes tumourigenicity in transgenic mice, confirming the oncogenic effect of BCL9L in cell culture and animal models [32]. This evidence concerns the gene BCL9L and breast cancer.